Strategic Investment from Sichuan Hebang Biotechnology
Avenira Limited (ASX: AEV) (“Avenira” or “the Company”)”) has secured a Strategic Investment from its largest shareholder, Sichuan Hebang Biotechnology...
Avenira Limited (ASX: AEV) (“Avenira” or “the Company”)”) has secured a Strategic Investment from its largest shareholder, Sichuan Hebang Biotechnology...
Famine has officially been declared in at least one refugee camp sheltering hundreds of thousands of people in the Darfur...
The children of two Russian intelligence agents, who were among the detainees released as part of a historic prisoner swap,...
The pounding of sustained gunfire and artillery had rattled Khin Swe’s home in northeastern Myanmar for days, with shelling getting...
The statement that upended Venezuela came 24 hours after polls closed in the presidential election. With the reassuring tone of...
Eight people were arrested and three police officers were injured during violent unrest in Britain’s northeast, the latest in a wave...
The broad market and the group are big drivers for stock performance. Recently, the Nasdaq 100 ETF (QQQ) led the...
And then ….. all of a sudden….. things are heating up. Lots of (downside) market action in the past week....
The dog days of summer are here. And the stock market gives us a brutal reminder of this. The first...
Carbon Done Right (TSXV: KLX), remains committed to completing a dual listing on London’s AIM Exchange, but will delay that...
Disclaimer: financemasterynews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.